Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD)

References

• American Psychiatric Association. 1994. Diagnostic and statistical manual ofmental disorders. 4th ed., Washington, DC: American Psychiatryc Press.
   Google Scholar
• Anderson RE, Sperling L. 1971. Positional distribution of the fatty acids in the phospholipids of bovine retina rod outer segments. Arch Biochem Biophys 144:673–677.
   PubMed Web of Science ®Google Scholar
• Armstrong VT, Brzustowicz MR, Wassal SR, Jenski LJ, Stillwell W. 2003. Rapid flip-flop in polyunsaturated (docosahexaenoate) phospholipid membranes. Arch Biochem Biophys 414:74–82.
   PubMed Web of Science ®Google Scholar
• Barkley RA. 1998. Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment. 2nd ed., New York: Guilford.
   Google Scholar
• Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, Pierce K, Wolraich ML. 2001. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 107:43–54.
   PubMed Web of Science ®Google Scholar
• Burgess JR, Stevens L, Zhang W, Peck L. 2000. Long-chain polyunsaturated fatty acids in children with attention- deficit hyperactivity disorder. Am J Clin Nutr 71(suppl): 327S-330S.
   PubMedGoogle Scholar
• Cacciari E, Milani S, Balsamo A, Dammacco F, De Luca F, Chiarelli F, Pasquino AM, Tonini G, Vanelli M. 2002. Italian cross-sectional growth charts for height, weight and BMI (6–20 y). Eur J Clin Nutr 56:171–180. Calder PC. 2003. N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 38:343–352.
   PubMed Web of Science ®Google Scholar
• Castellanos FX, et al. 2001. Neuroimaging studies of ADHD. In: Solanto MV, editor. Stimulant drugs and ADHD: Basic and clinical neuroscience. New York: Oxford University Press. p 243–258.
   Google Scholar
• Chauhan NB. 2003. Membrane dynamics, cholesterol homeostasis, and Alzheimer’s disease. J Lipid Res 44:2019–2029.
   PubMed Web of Science ®Google Scholar
• Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. 2000. Estabilishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 320:1–6.
   PubMed Web of Science ®Google Scholar
• Damsgaard CT, Schack-Nielsen L, Michaelsen KF, Fruekilde MB, Hels O, Lauritzen L. 2006. Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants. J Nutr 136: 94–99.
   PubMed Web of Science ®Google Scholar
• Dey AN, Shiller JS, Tai DA. 2002. Summary health statistics for U.S. children: National health interview survey. National Center for Health Statistics Vital and Health Stat 10:221.
   Google Scholar
• Elia J, Ambrosiani PJ, Rappoport JL. 1999. Treatment of attention- deficit-hyperactivity-disorder. New Engl J Med 11:780–788.
   Google Scholar
• Fan YY, McMurray DN, Ly LH, Chapkin RS. 2003. Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr 133:1913–1920.
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Sloane Stanley GH. 1957.A simple method for the isolation and purification oftotal lipids from animal tissues. J Biol Chem 226:497–509.
   PubMed Web of Science ®Google Scholar
• Goldman LS, Genel M, Bezman RJ, Slanetz PJ. 1998. Diagnosis and treatment of attention-deficit/hyperactivity-disorder in children and adolescents. JAMA 279:1100–1107.
   PubMed Web of Science ®Google Scholar
• Halperin JM, Newcorn JH, Schwartz ST, et al. 1993. Plasma catecholamine metabolite levels in ADHD boys with and without reading disabilities. J Clin Child Psycol 22:219–225.
   Web of Science ®Google Scholar
• Hamilton L, Greiner R, Salem N, Jr. 2000. N-3 fatty acid deficency decrease phosphatylserine accumulation selectively in neuronal tissues. Lipids 35:863–869.
   PubMed Web of Science ®Google Scholar
• Harbige LS. 2003. Fatty acids, the immune response, and autoimmunity: A question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38:323–341.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Hossain S, Agdul H, Shido O. 2005. Docosahex- aenoic acid-induced amelioration on impairment of memory learning in amyloid ß-infused rats relates to the decreases of amyloid ß and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta 1738:91–98.
   PubMed Web of Science ®Google Scholar
• Hirayama S, Hamazaki T, Terasawa K. 2004. Effect of docosahex- aenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder: A placebo-controlled double-blind study. Eur J Clin Nutr 58:467–473.
   PubMed Web of Science ®Google Scholar
• Huster D, Albert JJ, Arnold K, Gawrish K. 1997. Water permeability of polyunsaturated lipid membranes measured by 17O NMR. Biophys J 73:856–864.
   Google Scholar
• Kafrawy O, Zerouga M, Stillwell W, Jenski LJ. 1998. Docosahex- aenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids. Cancer Lett 132:23–29.
   PubMed Web of Science ®Google Scholar
• Kang JX. 2003. The importance of omega-omega-3 fatty acid ratio in cell function: The gene transfer of omega-3 fatty acid desaturase. World Rev Nutr Diet 92:23–36.
   PubMedGoogle Scholar
• Koenig BW, Strey HH, Gawrisch K. 1997. Membrane lateral compressibility determined by NMR and X-Ray diffraction: Effect of acyl chain polyunsaturation. Biophys J 73:1954–1966.
   PubMed Web of Science ®Google Scholar
• Litman BJ, Niu SL, Polozova A, Mitchell DC. 2001. The role of docosahexaenoic acid conteining phospholipids in modulating G protein-coupled signaling pathways: Visual transduction. J Mol Neurosci 16:237–243, discussion: 279–284.
   PubMed Web of Science ®Google Scholar
• Lobstein T, Frelut ML. 2003. Prevalence of overweight among children in Europe. Obes Rev 4:195–200.
   PubMedGoogle Scholar
• Luciano A, Bressan F, Zoppi G. 1997. Body mass index reference curves for children aged 3–19 years from Verona, Italy. Eur J Clin Nutr 51:6–10.
   PubMed Web of Science ®Google Scholar
• Mayman GA, Evans W, Restrepo H, Hutchins HL, Sears B. 2005. Effect of fish oil supplementation on metabolic syndrome and inflammatory parameters during the use of low glycemic load diets in the treatment of pediatric obesity. Communication at annual scientific meeting of American Diabetes Association.
   Google Scholar
• Millberger S, Biederman J, Faraone SV, Chen L, Jones J. 1996. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry 153:1138–1142.
   PubMed Web of Science ®Google Scholar
• Mugnaini D, Masi G, Brovedani P, Chelazzi C, Matas M, Romagnoli C, Zuddas A. 2005. Teacher reports of ADHD symptoms in Italian children at the end of first grade. Eur Psychiatry, [Epub aheadofprint] PMID: 15961290 [PubMed— as supplied by publisher].
   Google Scholar
• Nemets B, Stahl Z, Belmaker RH. 2002. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159:477–479.
   PubMed Web of Science ®Google Scholar
• Pearson S, Stern S, McGavack TH. 1953. A rapid accurate method for the determination of total cholesterol. Anal Chem 25: 313–314.
   Web of Science ®Google Scholar
• Peet M, Horrobin DF. 2002. A dose-ranging study of the effects of ethyl-eicosapentanoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59:913–919.
   PubMed Web of Science ®Google Scholar
• Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker J. 1994. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 33:1165–1173.
   PubMed Web of Science ®Google Scholar
• Richardson AJ. 2004a. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins leukot Essent Fatty Acids 70:383–390.
   PubMed Web of Science ®Google Scholar
• Richardson AJ. 2004b. Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids 39: 1215–1222.
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Montgomery P. 2005. The Oxford-Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115:1360–1366.
   PubMed Web of Science ®Google Scholar
• Rizzo AM, Galli CF, Montorfano G, Berra B. 1995. Phospholipid distribution and fatty acid composition in different brain regions during chick embryo development. J Neurochem 64: 1728–1733.
   PubMed Web of Science ®Google Scholar
• Ross BM, McKenzie I, Glen I, Bennett CP. 2003. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci 6:277–281.
   PubMed Web of Science ®Google Scholar
• SanGiovanni JP, Chew EY. 2005. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24:87–138.
   PubMed Web of Science ®Google Scholar
• Savani A, Nadkarni A. 1998. Attention deficit disorder, the ADD puzzle & some cognitive behavioral solutions Asian. J Pediatr Pract 2(2):45–48.
   Google Scholar
• Singh M. 2005. Essential fatty acids, DHA and human brain. [Review]. Indian J Pediatr 72:239–242.
   PubMedGoogle Scholar
• Sinopoulos AP. 2002. The importance of the ratio of omega- 6/omega-3 essential fatty acids. Biomed Pharmacother 56:365–379.
   PubMed Web of Science ®Google Scholar
• Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR. 1995. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 62: 761–768.
   PubMed Web of Science ®Google Scholar
• Stillwell W, Wassal SR. 2003. Docosahexaenoic acid: Membrane properties of a unique fatty acid. Chem Phys Lipids 126:1–27.
   PubMed Web of Science ®Google Scholar
• Swanson J, Deutsh C, Cantwell D. 2001. Genes and attention- deficit hyperactivity disorder. Clin Neurosci Res 1:207–216.
   Web of Science ®Google Scholar
• Thapar A, O’Donovan M, Owen MJ. 2005. The genetics of attention deficit hyperactivity disorder. [Review]. Hum Mol Genet 14(Spec No. 2):R275 -R282.
   PubMed Web of Science ®Google Scholar
• Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. 2001. Essential fatty acids in visual and brain development. [Review]. Lipids 36:885–895.
   PubMed Web of Science ®Google Scholar
• Vance DE, Sweeley CC. 1967. Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res 8: 621–630.
   PubMed Web of Science ®Google Scholar
• Vigh L, Escriba’ PV, Sonnleitner A, Sonnleitner M, Piotto S, Maresca B, Horvath I, Harwood JL. 2005. The significance of lipid composition for membrane activity: New concepts and ways of assessing function. Prog Lipid Res 44:303–344.
   PubMed Web of Science ®Google Scholar
• Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. 2001. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 139:189–196.
   PubMed Web of Science ®Google Scholar
• Wainwright PE. 2002. Dietary essential fatty acids and brain function: A developmental perspective on mechanisms. [Review]. Proc Nutr Soc 61(1):61–69.
   PubMed Web of Science ®Google Scholar
• Williams EE, Jensky LJ, Stillwell W. 1998. Docosahexaenoic acid (DHA) alters the structure and composition of membraneous vesicles exfoliated from the surface of a murine leukemia cell line. Biochim Biophys Acta 1371:351–362.
   PubMed Web of Science ®Google Scholar
• Yehuda S, Rabinovitz S, Mostofsky DI. 1998. Modulation of learning and neuronal membrane composition in the rat by essential fatty acid preparation: Time-course analysis. Neurochem Res 23:627–634.
   PubMed Web of Science ®Google Scholar